Adimmune Corporation develops, manufactures, and distributes human vaccines in Taiwan. The company’s primary products include AdimFlu-s (AH1N1), Japanese encephalitis vaccine, and tetanus toxoid alum precipitated, as well as influenza vaccine. It also provides fill and finish services; product testing and analysis of quality of vaccines and biological products, as well as other relevant tests; quality assurance courses, comprising introductory courses on GMP-related subjects to schools and industries; and consulting services, such as planning, design, construction, validation, and project management of biological product plant. In addition, the company rents cold storage facilities; and distributes Tuberculin PPD product. The company was formerly known as Kuo Kwang Serum and Vaccine Manufacture Co., Ltd. and changed its name to Adimmune Corporation in 2001. Adimmune Corporation was founded in 1965 and is based in Taichung, Taiwan.
(4142:Taiwan Stock Exchange)
No. 3, Tanxing Road
Phone: 886 4 2538 1220
Fax: 886 4 2539 5133www.adimmune.com.tw
|No competitor information is available for 4142.|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|
Sponsored Financial Commentaries
To contact ADIMMUNE CORP, please visit www.adimmune.com.tw. Company data is provided by Capital IQ. Please use this form to report any data issues.